DoseFit: GLP-1 Tracker & Diary
DoseFit is a health-tracking app for GLP-1 medication users on iOS, designed to log injections, side effects, and weight progress.
The App DNA
What makes this app unique?
The app removes the cognitive load of managing complex, long-term medication schedules by centralizing injection history and side-effect tracking in one dashboard.
For Individuals prescribed GLP-1 medications who require a centralized tool to track injections, side effects, and weight loss progress.
What does it look like?
Key features
Logs for GLP-1 injections and oral medications including dosage, schedules, and injection site history.
Visualizes estimated drug level trends based on public pharmaceutical data.
Food logging via photo recognition and search functionality for daily meal entries.
How much does it cost?
Subscription model anchored at $12.99/month, gating core medication and meal tracking features behind the paywall.
Velocity
Active developmentnew contentUX improvementsShow more...
DoseFit maintains an active development cadence, shipping 2 distinct versions over the observed window with an average of 1 release every 13 days. The latest release demonstrates a focus on functional utility by expanding dietary tracking capabilities. Development appears stable, with the team consistently iterating on core health-tracking features. The current pace suggests a commitment to regular feature refinement rather than sporadic maintenance.
Who built it?
The Trustee for Lotus Resort Trust
1 app tracked · Health & Fitness
Explore the full publisher profileUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for DoseFit: GLP-1 Tracker & Diary
How's the Health & Fitness market?
DoseFit operates in the specialized health-tracking category, maintaining a 4.75 rating across 225 reviews. The $12.99/month premium tier positions the app as a high-intent utility for users managing long-term medication routines.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for DoseFit: GLP-1 Tracker & Diary
Where is it heading?
The GLP-1 tracking market is consolidating as users seek specialized tools to manage complex, long-term treatment plans. DoseFit is well-positioned to retain high-intent users by focusing on medication-specific utility, provided the development cadence continues to outpace generic trackers.
- Frequent updates adding nutrient and calorie tracking indicate active development, which helps keep DoseFit relevant against generic health-tracking competitors.
- The focus on specialized GLP-1 features creates a distinct niche, protecting DoseFit from direct competition with broad-market apps that lack medication-specific tracking.
The SWOT
- Specialized injection-site logging creates a high-utility barrier for complex medication routines.
- Medication-level visualization provides authority in the GLP-1 tracking segment.
- Pharmacy-data sync could reduce user data-entry friction compared to manual-entry rivals.
Next best moves
A/B test a lower-priced monthly entry tier because the $12.99/month price point is above the category median → increase top-of-funnel conversion.
+ 1 more prioritized moveThe counter-intuitive read
The high subscription price is not a weakness…
Read the full takeBottom line
DoseFit maintains a defensible position by specializing in the administrative burden of GLP-1 treatment, but the premium subscription price requires consistent feature expansion to justify the cost against free, broad-market alternatives.
Unlock 1 critical friction, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated